Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Toyohiro Yamada"'
Autor:
Keita Nakane, Toyohiro Yamada, Risa Tomioka-Inagawa, Fumiya Sugino, Naotaka Kumada, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Koji Iinuma, Takuya Koie
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9294-9304 (2022)
To maintain a surgeon’s concentration, reduce fatigue, and train young surgeons, surgical procedures for bladder cancer are divided into the following parts: robot-assisted radical cystectomy (RARC), bowel reconstruction, and totally intracorporeal
Externí odkaz:
https://doaj.org/article/e077036fa9ce412a873f57c3224d67fc
Autor:
Hiroyuki Ito, Keita Nakane, Toyohiro Yamada, Kazuhiro Kobayashi, Tatsuhiko Miyazaki, Takuya Koie
Publikováno v:
Urology Case Reports, Vol 50, Iss , Pp 102477- (2023)
A 30-year-old man presented to his previous physician with left abdominal pain. Computed tomography revealed a left retroperitoneal mass with calcification, measuring 15 × 9 × 6 cm, and the patient was referred to our hospital for further examinati
Externí odkaz:
https://doaj.org/article/03b1c342172a49528dd49cd31ba682db
Autor:
Fumiya Sugino, Keita Nakane, Makoto Kawase, Shota Ueda, Masayuki Tomioka, Yasumichi Takeuchi, Risa Tomioka-Inagawa, Toyohiro Yamada, Sanae Namiki, Naotaka Kumada, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Koji Iinuma, Yuki Tobisawa, Takuya Koie
Publikováno v:
Life, Vol 13, Iss 5, p 1072 (2023)
Background: This retrospective single-center cohort study evaluated the efficacy and safety of a combination of neoadjuvant luteinizing hormone-releasing hormone (LHRH) antagonist and tegafur-uracil (UFT) therapy (NCHT) and investigated the medical r
Externí odkaz:
https://doaj.org/article/923c3c4b13874151809f06538c95d249
Autor:
Toyohiro Yamada, Keita Nakane, Torai Enomoto, Masayuki Tomioka, Tomoki Taniguchi, Takashi Ishida, Kaori Ozawa, Kimiaki Takagi, Hiroki Ito, Shinichi Takeuchi, Makoto Kawase, Kota Kawase, Daiki Kato, Manabu Takai, Koji Iinuma, Shigeaki Yokoi, Masahiro Nakano, Takuya Koie
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2243 (2022)
The treatment options are currently limited, and the oncological outcomes remain unclear, for patients with metastatic urothelial carcinoma (mUC) with or without third-line systemic therapy. We aimed to evaluate the oncological outcomes in real-world
Externí odkaz:
https://doaj.org/article/40b438f983d849e08e6d8958d3999ab4
Autor:
Koji Iinuma, Toyohiro Yamada, Koji Kameyama, Tomoki Taniguchi, Kei Kawada, Takashi Ishida, Shingo Nagai, Torai Enomoto, Shota Ueda, Kimiaki Takagi, Makoto Kawase, Shinichi Takeuchi, Kota Kawase, Daiki Kato, Manabu Takai, Keita Nakane, Takuya Koie
Publikováno v:
Cancers
Volume 15
Issue 3
Pages: 947
Volume 15
Issue 3
Pages: 947
We evaluated the efficacy and safety of combination therapy with immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKI) as first-line therapy for patients diagnosed as having advanced or metastatic renal cell carcinoma (mRCC). We en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba8671e4727d277f65d1e1aaff8fe55